[go: up one dir, main page]

SV2007002357A - DERIVED FROM QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT REF. P-SV-79232 / UG - Google Patents

DERIVED FROM QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT REF. P-SV-79232 / UG

Info

Publication number
SV2007002357A
SV2007002357A SV2005002357A SV2005002357A SV2007002357A SV 2007002357 A SV2007002357 A SV 2007002357A SV 2005002357 A SV2005002357 A SV 2005002357A SV 2005002357 A SV2005002357 A SV 2005002357A SV 2007002357 A SV2007002357 A SV 2007002357A
Authority
SV
El Salvador
Prior art keywords
preparation
quinolina
ref
derived
product containing
Prior art date
Application number
SV2005002357A
Other languages
Spanish (es)
Inventor
Wolfgang Schwede
Antonius Ter Laak
Stefan Jaroch
Benjamin Bader
Roman Hillig
Dieter Zopf
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SV2007002357A publication Critical patent/SV2007002357A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN DERIVADO DE QUINOLINA DE LA FORMULA GENERAL A, VER FORMULA,EN LA QUE R1, R2, R3, X, Y, Z Y A SE INDICAN EN LA DESCRIPCION Y EN LAS REIVINDICACIONES, AL USO DE LOS COMPUESTOS LA FORMULA GENERAL A PARA EL TRATAMIENTO DE DIVERSAS ENFERMEDADES, ASI COMO A LA PREPARACION DE COMPUESTOS LA FORMULA GENERAL ATHE PRESENT INVENTION REFERS TO A QUINOLINE DERIVATIVE OF THE GENERAL FORMULA A, SEE FORMULA, IN WHICH R1, R2, R3, X, Y, ZYA ARE INDICATED IN THE DESCRIPTION AND IN THE CLAIMS, TO THE USE OF THE COMPOUNDS THE FORMULA GENERAL A FOR THE TREATMENT OF VARIOUS DISEASES, AS WELL AS TO THE PREPARATION OF COMPOUNDS THE GENERAL FORMULA A

SV2005002357A 2004-12-22 2005-12-22 DERIVED FROM QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT REF. P-SV-79232 / UG SV2007002357A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004063223A DE102004063223A1 (en) 2004-12-22 2004-12-22 New quinoline derivatives are ephrin receptor kinase inhibitors useful for the treatment of e.g. blood vessels diseases, hyperproliferations, chronic or acute neurodegenerative diseases, psoriasis, eczema and scleroderma

Publications (1)

Publication Number Publication Date
SV2007002357A true SV2007002357A (en) 2007-02-16

Family

ID=36599298

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2005002357A SV2007002357A (en) 2004-12-22 2005-12-22 DERIVED FROM QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT REF. P-SV-79232 / UG

Country Status (7)

Country Link
CN (1) CN101087788A (en)
AR (1) AR052544A1 (en)
DE (1) DE102004063223A1 (en)
GT (1) GT200500381A (en)
PA (1) PA8657701A1 (en)
SV (1) SV2007002357A (en)
UY (1) UY29308A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103382206B (en) * 2012-05-04 2016-09-28 上海恒瑞医药有限公司 Quinoline or quinazoline derivative, its preparation method and in application pharmaceutically
CN106565823B (en) * 2016-11-10 2020-09-11 珠海诺贝尔国际生物医药研究院有限公司 Eph receptor small molecule inhibitor and preparation method thereof
CN110577546B (en) * 2018-06-08 2021-09-07 江苏威凯尔医药科技有限公司 VEGFR inhibitor and preparation method and application thereof
WO2019233458A1 (en) * 2018-06-08 2019-12-12 江苏威凯尔医药科技有限公司 Vegfr inhibitor, preparation method therefor and use thereof
CN113150009B (en) * 2020-01-07 2023-05-23 爱科诺生物医药(香港)有限公司 Heterocyclic compound with activity of inhibiting programmed cell necrosis pathway and application thereof
CN113061142B (en) * 2020-01-02 2024-08-27 爱科诺生物医药(香港)有限公司 Heterocyclic compound with activity of inhibiting programmed cell necrosis pathway and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919238A (en) * 1973-06-06 1975-11-11 Morton Norwich Products Inc 9-(Substituted amino)imidazo(4,5-f) quinolines
EP0187705A3 (en) * 1985-01-08 1988-05-11 Norwich Eaton Pharmaceuticals, Inc. Imidazo(4,5-f)quinolines useful as immunomodulating agents
FI940469A7 (en) * 1991-08-02 1994-02-01 Pfizer Quinoline derivatives as immunostimulants

Also Published As

Publication number Publication date
DE102004063223A1 (en) 2006-07-13
CN101087788A (en) 2007-12-12
PA8657701A1 (en) 2006-09-08
GT200500381A (en) 2006-08-03
UY29308A1 (en) 2006-06-30
AR052544A1 (en) 2007-03-21

Similar Documents

Publication Publication Date Title
UY28369A1 (en) THERAPEUTIC AGENTS
CR9834A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF EZQUIZOPHRENIA
UY30327A1 (en) NEW COMPOUNDS II
UY31524A1 (en) NEW COMPOUNDS 010
CR6726A (en) AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO
CR10304A (en) TETRAHYDROPIRIDOTIENOPIRIMIDINE COMPOUNDS AND PROCEDURES FOR THE SAME USE
UY29886A1 (en) NEW PIRAZOL DERIVATIVES, PHARMACCUTIC COMPOSITIONS CONTAINING THEM, PROCEDURES FOR THE PREPARATION OF THE SAME AND APPLICATIONS
UY31481A1 (en) NEW PIRIMIDINE DERIVATIVES, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS
UY29795A1 (en) ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCESSES AND APPLICATIONS
UY28144A1 (en) THERAPEUTIC AGENTS
ECSP11011113A (en) VEGF-R2 PIRIDYLOXI-INDOLES INHIBITORS AND USE OF THE SAME FOR THE TREATMENT OF DISEASES
CR10489A (en) PHENYL-PIRAZOL DERIVATIVES AS LEGANDS OF NON-STEROID GLUCOCORTICOID RECEPTORS
CR9954A (en) PIRAZINE DERIVATIVES
HN2008001666A (en) ACID DERIVATIVES OF CICLOALQUILAMINO
CR9223A (en) 18-METIL-19-NOR-17-PREGN-4-EN-21, 17-CARBOLACTONES, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM
SV2007002007A (en) SUBSTITUTED QUINOLINE COMPOUNDS REF. PC 25932A
PA8621901A1 (en) SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DISEASES
UY30460A1 (en) THERAPEUTIC COMPOUNDS
UY29002A1 (en) NEW HIDANTOINE DERIVATIVES, PARASU PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPY
ECSP099425A (en) DERIVATIVES OF AMINA AND ITS USE IN DISEASES MEDIATED BY THE BETA 2 ADRENORECETOR
CR9182A (en) DERIVATIVE OF QUINOLINA, ITS USE, PREPARATION AND MEDICINAL PRODUCT CONTAINING IT
PA8568101A1 (en) INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE
UY30451A1 (en) 18-METIL-19-NOR-ANDROST-4-EN-17,17-ESPIROÉTERES (18-METIL-19-NOR-20-ESPIROX-4-EN-3-ONAS), ASE AS PHARMACEUTICAL PREPARATIONS CONTAINING IT.
HN2010000330A (en) DERIVATIVES OF INDOL-2-ONA DISPOSED IN 3 AND ITS PREPARATION
PA8589801A1 (en) AMINOALCOXYINDOLS

Legal Events

Date Code Title Description
FD Lapse